Jan 24th, 2025
Merck KGaA CEO Belen Garijo at Davos
Germany's Merck KGaA is betting on partnerships to boost its biopharma business. Speaking with Bloomberg TV on the sidelines of the 2025 World Economic Forum in Davos, Merck KGaA CEO Belen Garijo said immunology and oncology are some of the main areas of collaboration.



